v3.25.2
Condensed Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 319,000 $ 9 $ 112,947,098 $ (100,160,891) $ 13,105,216
Balance (in Shares) at Dec. 31, 2023 106,333 86,017      
Stock-based compensation expense 826,198 826,198
Issuance of restricted stock 2,888 2,888
Issuance of restricted stock (in Shares)   1,848      
Common stock withheld to pay taxes (4,235) (4,235)
Common stock withheld to pay taxes (in Shares)   (121)      
Fees incurred in connection with equity offerings (32,170) (32,170)
Series C preferred stock dividends (150,000) (150,000)
Net loss (3,783,400) (3,783,400)
Balance at Jun. 30, 2024 $ 319,000 $ 9 113,589,779 (103,944,291) 9,964,497
Balance (in Shares) at Jun. 30, 2024 106,333 87,744      
Balance at Mar. 31, 2024 $ 319,000 $ 9 113,258,047 (101,905,434) 11,671,622
Balance (in Shares) at Mar. 31, 2024 106,333 86,017      
Stock-based compensation expense 408,512 408,512
Issuance of restricted stock 2,888 2,888
Issuance of restricted stock (in Shares)   1,848      
Common stock withheld to pay taxes (4,235) (4,235)
Common stock withheld to pay taxes (in Shares)   (121)      
Fees incurred in connection with equity offerings (433) (433)
Series C preferred stock dividends (75,000) (75,000)
Net loss (2,038,857) (2,038,857)
Balance at Jun. 30, 2024 $ 319,000 $ 9 113,589,779 (103,944,291) 9,964,497
Balance (in Shares) at Jun. 30, 2024 106,333 87,744      
Balance at Dec. 31, 2024 $ 791,245 $ 240 118,758,356 (109,164,636) 10,385,205
Balance (in Shares) at Dec. 31, 2024 106,953 2,397,794      
Stock-based compensation expense 817,503 817,503
Issuance of restricted stock $ 19 17,503 17,522
Issuance of restricted stock (in Shares)   186,900      
Sale of common stock, warrants and pre-funded warrants pursuant to a registration statement on Form S-1 $ 226 14,377,609 14,377,835
Sale of common stock, warrants and pre-funded warrants pursuant to a registration statement on Form S-1 (in Shares)   2,260,000      
Fees incurred in connection with equity offerings (1,830,459) (1,830,459)
Warrants exercised for common stock $ 2,215 19,932 22,147
Warrants exercised for common stock (in Shares)   22,146,750      
Warrants exercised for common stock on a cashless basis $ 54,916 (54,916)
Warrants exercised for common stock on a cashless basis (in Shares)   549,151,875      
Conversion of Series H preferred stock for common stock $ (472,245) $ 16 472,229
Conversion of Series H preferred stock for common stock (in Shares) (310) 161,780      
Redemption of Series I preferred stock
Redemption of Series I preferred stock (in Shares) (310)        
Series C preferred stock dividends (150,000) (150,000)
Net loss (4,243,658) (4,243,658)
Balance at Jun. 30, 2025 $ 319,000 $ 57,632 132,427,757 (113,408,294) 19,396,095
Balance (in Shares) at Jun. 30, 2025 106,333 576,305,099      
Balance at Mar. 31, 2025 $ 319,000 $ 16,737 132,226,723 (111,355,622) 21,206,838
Balance (in Shares) at Mar. 31, 2025 106,333 167,359,224      
Stock-based compensation expense 380,693 380,693
Fees incurred in connection with equity offerings (63,764) (63,764)
Warrants exercised for common stock on a cashless basis $ 40,895 (40,895)
Warrants exercised for common stock on a cashless basis (in Shares)   408,945,875      
Series C preferred stock dividends (75,000) (75,000)
Net loss (2,052,672) (2,052,672)
Balance at Jun. 30, 2025 $ 319,000 $ 57,632 $ 132,427,757 $ (113,408,294) $ 19,396,095
Balance (in Shares) at Jun. 30, 2025 106,333 576,305,099